Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/ΔNS2/Δ1313/I1314L and RSV/276 in RSV Seronegative Children.

Coleen K CunninghamRuth A KarronPetronella MuresanMatthew S KellyElizabeth J McFarlandCharlotte PerlowskiJennifer LibousJennifer OlivaPatrick Jean-PhilippeJack MoyeElizabeth SchappellEmily BarrVivian RexroadBenjamin JohnstonEllen G ChadwickMikhaela CieloMary PaulJaime G DevilleMariam AzizLijuan YangCindy LuongoPeter L CollinsUrsula J Buchholznull null

Published in: The Journal of infectious diseases (2022)

Both vaccines had excellent infectivity and were well-tolerated. RSV/276 induced an excess of mild cough. Both vaccines were immunogenic and primed for strong anamnestic responses.

Keyphrases

respiratory syncytial virus
young adults
high glucose
diabetic rats
dengue virus
cell free
endothelial cells
zika virus
aedes aegypti